Hepatitis Hepatitis

Hepatitis C virus, via transmission electron microscopy. (The actual viral diameter is around 22 nm.) Doctors say the recent FDA approval of Mavyret, a less expensive drug for treating the virus, may make it easier for more insurers and correctional facilities to expand treatment. James Cavallini/Science Source hide caption

toggle caption
James Cavallini/Science Source

Needles at the Alaska AIDS Assistance Association syringe exchange in Anchorage. Zachariah Hughes/Alaska Public Media hide caption

toggle caption
Zachariah Hughes/Alaska Public Media

Syringe Exchange Program Aims To Slow Hepatitis C Infections In Alaska

  • Download
  • <iframe src="https://www.npr.org/player/embed/547054395/547113317" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Gilead Sciences Inc. makes the two leading drugs that can quickly cure hepatitis C infections. But most patients can't afford the expensive drugs, and states restrict their use among Medicaid patients. David Paul Morris/Bloomberg via Getty Images hide caption

toggle caption
David Paul Morris/Bloomberg via Getty Images

Should The U.S. Government Buy A Drug Company To Save Money?

  • Download
  • <iframe src="https://www.npr.org/player/embed/520430944/520576934" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript